Johanna Kneidinger

Ms. Johanna Kneidinger

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2025 in Behavioral Sciences
Verified
Journal Article
Open access
PDF file
Emily RaaschEmily Raasch
Emily Raasch
AFAnselm B. M. Fuermaier
Anselm B. M. Fuermaier
JKJohanna Kneidinger
Johanna Kneidinger
BABjörn Albrecht
Björn Albrecht
Hanna ChristiansenHanna Christiansen
Hanna Christiansen
Performance validity tests (PVTs) and symptom validity tests (SVTs) are central to evaluating neuropsychological test results in clinical adult ADHD assessments. Although their relationships have been widely examined, the constructs these measures assess remain poorly understood in applied contexts. This study investigates the conceptual similarities and distinctions of performance validity measures, i.e., the Groningen Effort Test (GET), the Medical Symptom Validity Test (MSVT), and the Amsterdam Short-Term Memory (ASTM) test, within a comprehensive diagnostic battery for adult ADHD. The diagnostic battery included symptom self-reports and a continuous performance test (CPT). Network and factor analyses investigated these relationships. A three-factor structure was hypothesized, consisting of (1) performance validity measures, (2) continuous performance measures, and (3) symptom reports (including embedded SVTs). Data from a large clinical referral sample (N = 461) of adults with suspected ADHD were analyzed to explore these constructs. Network analysis revealed that the PVTs did not form a cohesive network with CPT measures. Symptom reports, including embedded SVTs, formed their own cluster, separate from performance-based attention measures. Factor analysis rejected a unified construct of performance validity measures. Regression analysis showed that cognitive deficits, education level, and impulsivity predicted ASTM test performance, whilst the MSVT and GET did not. These findings suggest that PVTs should be interpreted in the context of ADHD assessment, particularly in high-stakes forensic evaluations, where the accuracy of performance evaluation is critical. Future research should explore multidimensional models of performance validity, addressing domain-specific underperformance and individual variability in ADHD evaluations.

3 October 2024 in Child and Adolescent Psychiatry and Mental Health
Verified
Journal Article
Open access
PDF file
JKJohanna Kneidinger
Johanna Kneidinger
JAJosé C. García Alanis
José C. García Alanis
RSRicarda Steinmayr
Ricarda Steinmayr
SSSilvia Schneider
Silvia Schneider
Hanna ChristiansenHanna Christiansen
Hanna Christiansen
Having control over your own behavior and impulses is a critical skill that influences children’s academic, social, and emotional development. This study investigates the stability and predictive relationships between parents’ ratings of their own and their children’s executive function and delay aversion. Using data from approximately 1700 families collected during the COVID-19 pandemic, we employed hierarchical structural equation models and cross-lagged panel models to analyze the temporal stability and directional influences of executive function and delay aversion assessments. Our analysis revealed a substantial latent correlation (r = 0.48, p < 0.001) between parents’ and children’s executive function problems, indicating a shared variance of approximately 23%. Significant cross-lagged effects were found, with parental executive functions at T1 predicting child executive functions at T2 (β = 0.16, p = 0.005). For delay aversion, we found a latent correlation of r = 0.53 (p < 0.001) and significant within-timepoint and temporal stability, but no cross-lagged effects. These findings suggest that higher levels of executive function problems reported by parents at T1 correspond to an increased perception of similar problems in their children at T2. This highlights the importance of parental self-perception in assessing children’s abilities. Our results highlight the importance of incorporating family dynamics into interventions targeting executive function difficulties and delay aversion in children, and understanding this interplay enables the development of more effective, individualized approaches to support positive developmental outcomes.

1 January 2026 in Lernen und Lernstörungen
Verified
Journal Article
Open access
JKJohanna Kneidinger
Johanna Kneidinger
ASAnna Szép
Anna Szép
Hanna ChristiansenHanna Christiansen
Hanna Christiansen
Zusammenfassung: Hintergrund: Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) wird bei männlichen Personen häufiger diagnostiziert als bei weiblichen. Ziel dieser Arbeit ist, Ursachen und ihre Auswirkungen auf die Diagnostik und Behandlung von Frauen zu untersuchen. Diagnoseinstrumente, meist an männlichen Stichproben validiert, bilden weibliche Symptome nur unzureichend ab. Methode: Im Rahmen dieser Übersichtsarbeit wurden zentrale Aspekte einer weiblichen ADHS identifiziert, die in Forschung und Praxis als besonders relevant gelten. Diese Schwerpunkte wurden anhand aktueller Fachliteratur vertieft untersucht. Diskussion: Geschlechtsspezifische Unterschiede in der Symptomatik erschweren eine frühzeitige Diagnose und adäquate Behandlung bei Frauen. Weniger externale Symptome, Maskierungsstrategien sowie Veränderungen im Hormon- und Neurotransmitterhaushalt beeinträchtigen das Erkennen zusätzlich. Erwachsene Informant_innen erkennen Symptome bei Frauen weniger zuverlässig, was zu Verzerrungen führt. Es braucht geschlechtersensible diagnostische und therapeutische Verfahren. Bis dahin sollten verstärkt Selbstberichte genutzt und diagnostische Kriterien für Erwachsene bei Mädchen früher angewendet werden. Da Mädchen im Schulalter häufig über besser entwickelte exekutive Funktionen (EF) verfügen, sind sie eher in der Lage, Symptome zu maskieren, weshalb gute Schulleistungen nicht als Hinweis gegen eine Diagnose gewertet werden sollten. Hormonelle Einflüsse sollten Berücksichtigung finden.

31 July 2026 in Child and Adolescent Psychiatry and Mental Health
Verified
Journal Article
Open access
PDF file
SBSabrina Berardi
Sabrina Berardi
Hanna ChristiansenHanna Christiansen
Hanna Christiansen
SDSebastian Deutscher
Sebastian Deutscher
DEDavid Daniel Ebert
David Daniel Ebert
RERebekka Eilers
Rebekka Eilers
RSRegina Steil
Regina Steil
Introduction: Cognitive ability has been linked to posttraumatic stress disorder (PTSD) vulnerability and may influence trauma-focused treatment response, yet its role in youth Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) outcomes remains unclear. Clarifying this issue is relevant for equitable access to evidence-based care. We examined whether formally assessed IQ was associated with PTSD symptom change from pre- to post-treatment based on youth and caregiver reports and with treatment dropout in children and adolescents undergoing TF-CBT after abuse or neglect. Method: Data came from N = 320 youth aged 5–21 years from a randomized clinical effectiveness trial. Intelligence quotient (IQ) was assessed with standardized tests, PTSD symptoms with the Child and Adolescent Trauma Screen (CATS-2), and dropout was defined as not completing therapy as intended. Symptom change was calculated as post- (T1) minus pre-treatment (T0) and evaluated separately for youth and caregiver reports. Regression models included age, gender, baseline PTSD severity, and treatment satisfaction assessed after treatment as an additional model variable. Results: Mean IQ was M = 97.41 ( SD = 13.19, range = 51–138). PTSD severity was high at baseline ( M = 34.21, SD = 8.09) and decreased substantially (ΔCATS-2 T1 ₋ T0 youth report: M = −17.54, SD = 12.34; Cohen’s d paired = 1.42). IQ showed small but significant negative correlations with symptom change in youth reports ( r = −.14, p = .040) and caregiver reports ( r = −.17, p = .018), indicating greater symptom reductions at higher IQ. In regressions, IQ was not a significant predictor in the youth-report model (β = −.10, p = .077), while a small effect remained in the caregiver-report model (β = −.15, p = .011). Baseline PTSD severity and post-treatment satisfaction showed more consistent associations with symptom reduction. Dropout was 29.1%. IQ neither differed between completers and dropouts nor was associated with dropout in logistic regression (OR = 0.99, p = .536), whereas higher post-treatment satisfaction was associated with lower dropout risk. Discussion: TF-CBT was associated with substantial symptom reductions across the observed IQ range, suggesting its suitability for routine care without excluding youth solely on the basis of cognitive ability. Baseline severity and treatment satisfaction at post-treatment showed stronger associations with symptom change and dropout than IQ. Trial registration The BESTFORCAN study was registered in the German Clinical Trial Registry (DRKS00020516) on 12 February 2020.